Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-10-22

FDA Approved: FYCOMPA — Original Application (Eisai Inc.)

View source ↗

Summary

FDA approved FYCOMPA (perampanel) through Eisai's original NDA for treatment of seizures associated with epilepsy, beginning with partial-onset seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fycompa (perampanel)

Snippet

ORIG AP for FYCOMPA (PERAMPANEL)